サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1405827

経カテーテル心臓弁の市場規模、シェア、動向分析レポート：用途別、技術別、地域別、セグメント予測、2023年～2030年

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report By Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), By Technology, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 81 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
経カテーテル心臓弁の市場規模、シェア、動向分析レポート：用途別、技術別、地域別、セグメント予測、2023年～2030年
出版日: 2023年12月08日
発行: Grand View Research
ページ情報: 英文 81 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル心臓弁市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の経カテーテル心臓弁の市場規模は、2023年から2030年にかけて15.2%のCAGRで推移し、2030年までには130億米ドルに達すると予測されています。

これらの製品は、通常の弁手術を受けることができない高齢者患者にのみ承認されているため、現在、市場は十分に浸透していません。慢性心血管病の有病率の増加、経済発展の増加、償還シナリオの改善、新技術の迅速な採用などの成長促進要因は、予測期間中に使用率を大幅に改善すると予想されます。

経カテーテル心臓弁市場は、Edwards Life Sciences、Medtronic、 St. Jude、oston Scientificといった主要市場プレーヤーによる研究開発への継続的な投資により、急速に進化しています。SAPIEN 3経カテーテル心臓弁やTRINITY弁のような技術的に先進的な製品は、手術合併症を減らし、患者のコンプライアンスを向上させるように設計されています。例えば、TRINITY TAVIシステムは、患者の安全性と治療成績を損なうことなく、デバイスの容易な回収と再配置を可能にします。

さらに、投資家の関心の高まり、有利な製品パイプライン、迅速な規制当局の承認、潜在的新興企業の買収競争の激化などにより、市場は強い追い風を受けると予想されます。例えば、Goldman SachsによるVenus MedTechの3,700万米ドルの資金調達など、同市場への注目すべき投資があります。市場動向に合わせて、Boston Scientific、Edward Life Sciences、Medtronicなどの市場参入企業も、僧帽弁閉鎖不全症や三尖弁置換術の新製品開発のために投資を増やしています。

経カテーテル心臓弁市場レポートハイライト

  • 大動脈弁狭窄症は最も蔓延している弁膜症であり、治療しなければ死に至ることもあります。経カテーテル大動脈弁セグメントは2022年に84.55%の最大市場シェアを占めました。
  • しかし、予測期間中、経カテーテル僧帽弁セグメントのCAGRは23.0%と最も高くなると予想されています。2013年10月に米国FDAが経カテーテル僧帽弁修復デバイスを承認したことが、このセグメントの成長の主要な推進力となっています。
  • 北米は2022年に約48.4％の最大シェアを占めました。対象人口が多いこと、可処分所得が高いこと、償還の枠組みがしっかりしていることなど、さまざまな要因が組み合わさって、この地域の高収益に貢献しています。
  • アジア太平洋地域は、予測期間中に最も速いCAGRを記録すると予想されます。疾患負担の増加、臨床試験規制の改善、先端医療技術への嗜好の高まり、医療ツーリズムの増加、医療分野への投資に対する特別な優遇措置などが、この地域の成長を強く後押しすると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 経カテーテル心臓弁の市場変数：動向と範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 経カテーテル心臓弁市場分析ツール
    • 業界分析-ポーターのファイブフォース分析
    • PESTEL分析

第4章 経カテーテル心臓弁市場：アプリケーションの推定・動向分析

  • 経カテーテル心臓弁市場：重要なポイント
  • 経カテーテル心臓弁市場：動向と市場シェア分析；2022年・2030年
  • 経カテーテル大動脈弁
    • 経カテーテル大動脈弁市場推計・予測；2018年～2030年
  • 経カテーテル肺動脈弁
    • 経カテーテル肺動脈弁市場推計・予測；2018年～2030年
  • 経カテーテル僧帽弁
    • 経カテーテル僧帽弁市場推計・予測；2018年～2030年

第5章 経カテーテル心臓弁市場：技術推定・動向分析

  • 経カテーテル心臓弁市場：重要なポイント
  • 経カテーテル心臓弁市場：動向と市場シェア分析；2022年・2030年
  • バルーン拡張経カテーテル弁
    • バルーン拡張経カテーテル弁市場推計・予測；2018年～2030年
  • 自己拡張型経カテーテル弁
    • 自己拡張型経カテーテル弁市場推計・予測；2018年～2030年

第6章 経カテーテル心臓弁市場：地域推定・動向分析

  • 地域別の見通し
  • 地域別の経カテーテル心臓弁市場：重要なポイント
  • 北米
    • 市場推計・予測；2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 最近の開発と影響分析；主要市場参入企業別
  • 市場参入企業の分類
    • Boston Scientific Corporation
    • Bracco Group
    • Braile Biomedica
    • Direct Flow Medical
    • Edwards Lifesciences
    • JenaValve, St. Jude Medical
    • Symetis
    • ValveXchange, Inc
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 3 North America transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 7 Canada transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Europe transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Europe transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 13 Germany transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 14 UK transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 15 UK transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 16 France transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 17 France transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Italy transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 19 Italy transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Spain transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 21 Spain transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Sweden transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 23 Sweden transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Norway transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 25 Norway transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Denmark transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 27 Denmark transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 31 China transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 32 China transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Japan transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 34 Japan transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 35 India transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 36 India transcatheter heart valve market, by technology, (USD Million) 2018 - 2030
  • Table 37 Australia transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 38 Australia transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Thailand transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 41 South Korea transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 42 South Korea transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Latin America transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Latin America transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 47 Brazil transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Mexico transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 49 Mexico transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Argentina transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 59 UAE transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Kuwait transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Transcatheter heart valve: Market outlook
  • Fig. 9 Transcatheter heart valve: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Transcatheter heart valve market driver impact
  • Fig. 15 Transcatheter heart valve market restraint impact
  • Fig. 16 Transcatheter heart valve market strategic initiatives analysis
  • Fig. 17 Transcatheter heart valve market: Application movement analysis
  • Fig. 18 Transcatheter heart valve market: Application outlook and key takeaways
  • Fig. 19 Transcatheter aortic valve market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Transcatheter pulmonary valve market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Transcatheter mitral valve market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Transcatheter heart valve market: Technology movement analysis
  • Fig. 23 Transcatheter heart valve market: Technology outlook and key takeaways
  • Fig. 24 Balloon expanded Transcatheter valve market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Self-expanded Transcatheter valve market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Global Transcatheter heart valve market: Regional movement analysis
  • Fig. 27 Global Transcatheter heart valve market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-096-5

Transcatheter Heart Valve Market Growth & Trends:

The global transcatheter heart valve market size is anticipated to reach a value of USD 13.0 billion by 2030, registering at a CAGR of 15.2% from 2023 to 2030,according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Transcatheter Heart Valve Market Report Highlights:

  • Aortic stenosis is the most prevalent valve disease, and if untreated it can lead to death. The transcatheter aortic valve segment accounted for the largest market share of 84.55% in 2022.
  • However, the transcatheter mitral valve segment is expected to have the highest CAGR of 23.0% over the forecast period. The U.S. FDA approval of the transcatheter mitral repair device in October 2013 is a key driver of the growth of this segment.
  • North America held the maximum share of nearly 48.4% in 2022. A combination of different factors such as the presence of large target population, high disposable income, strong reimbursement framework, contribute toward the high revenue generated in this region.
  • Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Increasing disease burden, improvement in clinical trial regulations, growing preference for advanced medical technologies, increase in medical tourism, and special incentives for investments in healthcare sector are expected to strongly favor the growth in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Application
    • 1.1.2. Technology
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables; Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Transcatheter Heart Valve Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis

  • 4.1. Transcatheter Heart Valve Market: Key Takeaways
  • 4.2. Transcatheter Heart Valve Market: Movement & Market Share Analysis; 2022 & 2030
  • 4.3. Transcatheter Aortic Valve
    • 4.3.1. Transcatheter aortic valve market estimates and forecasts; 2018 to 2030 (USD Million)
  • 4.4. Transcatheter Pulmonary Valve
    • 4.4.1. Transcatheter pulmonary valve market estimates and forecasts; 2018 to 2030 (USD Million)
  • 4.5. Transcatheter Mitral Valve
    • 4.5.1. Transcatheter mitral valve market estimates and forecasts; 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Transcatheter Heart Valve Market: Key Takeaways
  • 5.2. Transcatheter Heart Valve Market: Movement & Market Share Analysis; 2022 & 2030
  • 5.3. Balloon Expanded Transcatheter Valve
    • 5.3.1. Balloon expanded transcatheter valve market estimates and forecasts; 2018 to 2030 (USD Million)
  • 5.4. Self-Expanded Transcatheter Valve
    • 5.4.1. Self-expanded transcatheter valve delivery market estimates and forecasts; 2018 to 2030 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Transcatheter Heart Valve Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts; 2018 - 2030 (Revenue; USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis; By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Boston Scientific Corporation
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Bracco Group
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Braile Biomedica
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Direct Flow Medical
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Edwards Lifesciences
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. JenaValve, St. Jude Medical
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Symetis
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. ValveXchange, Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives